Clinical Trials Logo

Nocturnal Enuresis clinical trials

View clinical trials related to Nocturnal Enuresis.

Filter by:

NCT ID: NCT03733873 Completed - Clinical trials for Monosymptomatic Nocturnal Enuresis

Study on Chinese and Western Medicine in MNE Children

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Monosymptomatic nocturnal enuresis (MNE) is a common pediatric developmental disorder. MNE refers to urinary incontinence in the sleep state in children aged ≥5 years, without other LUT symptoms, and without bladder dysfunction. Its pathogenesis mainly include overnight polyuria, overactive bladder, sleep-arousal dysfunction, genetics, and abnormal secretion of anti-diuretic hormone (ADH). Desmopressin is a synthetic analog of ADH arginine-vasopressin (AVP), which is used to treat central diabetes insipidus and primary nocturnal enuresis (PNE). Desmopressin decreases urine production at night when taken at bedtime. Insufficient ADH secretion at night will contribute to nocturnal polyuria, which is an important cause of NE. Therefore, desmopressin, a synthetic analog of ADH, is frequently used for NE and is an evidence-based therapy (grade ⅠA evidence). Some children, however, have desmopressin resistance and do not achieve the desired treatment goals. What's more,there's a high relapse rate of desmopressin after withdrawing. Suoquan mixture is a Chinese medicine commonly used to treat NE in children. It is composed of Cuscuta, Codonopsis, Psoralea corylifolia Linn ,Astragalus,mantis egg-case and ephedra. It has not only a certain cure rate but also has a lower relapse rate . However there's few evidence could prove that. In this study,the investigators compared the 3 month treatment response and relapse rate (RR) in the following 6 months of desmopressin and desmopressin plus suoquan, and observe if there will be a lower relapse rare in desmopressin plus Suoquan. Moreover, the investigators will try to explore the mechanism of Suoquan mixture in MNE.

NCT ID: NCT03543995 Completed - Spina Bifida Clinical Trials

The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

It is claimed that SBO may be responsible for bladder dysfunction in patients without known neurological disease. Subsequently, it was reported that the frequency of SBO in NE cases was higher than normal children. However, in controlled trials, SBO frequency was not different in NE patients compared to the normal population. Conversely, the incidence of dysfunctional bladder in the presence of SBO in NE patients was found to be higher and the response to treatment was worse than in non-SBO patients. The present study aimed to determine whether the frequency of SBO in patients with NE was higher than in healthy subjects, the effect of SBO on the severity of LUTS and whether treatment response of primary NE patients changed in the presence of SBO.

NCT ID: NCT03522818 Recruiting - Enuresis, Nocturnal Clinical Trials

Enuresis Alarm - Is a Manual Trigger System Beneficial?

Start date: March 9, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether the bedwetting alarm trigger activated by parents to wake their child, in addition to the moisture alarm, will improve treatment success compared to the moisture alarm alone.

NCT ID: NCT03510975 Completed - Nocturnal Enuresis Clinical Trials

A New Check-list Method for Nocturnal Enuresis

Start date: January 1, 2015
Phase: Phase 4
Study type: Interventional

The study is aimed to demonstrate the benefits of newly formed written check-list of behavioral instructions and investigate its effects on parent's awareness, consciousness and motivation toward MNE. The parents with children who complain of bed-wetting 3 or more nights per week for at last 14 days, they was randomly divided into three groups. The parents in Group I were instructed only a verbal behavioral therapy, the parents in Group II were instructed a behavioral therapy with a written formed check-list for parents to fulfill and the children in Group III will received desmopressin treatment plus verbal behavioral therapy. All participants were analysed the compliance and response rate of treatment over time period of 8 week.

NCT ID: NCT03478813 Withdrawn - Enuresis Clinical Trials

Voiding School as a Treatment of Children's Day-time Incontinence or Enuresis

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The Voiding School is a simple educational intervention to treat children with daytime incontinence or enuresis.The purpose of this study is to implement the intervention in primary care, child welfare clinics. Half of the participated children will receive treatment according the Voiding School protocoll and half of them will receive treatment as usual. Patient outcomes are evaluated by measuring changes in wetting episodes. Aim is also to evaluate the implementation process.

NCT ID: NCT03477812 Recruiting - Nocturnal Enuresis Clinical Trials

Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study

Start date: January 22, 2018
Phase:
Study type: Observational

Full ambulatory polysomnography at home performed two nights in 30 healthy children and one night in 30 children with mono-symptomatic nocturnal enuresis (15 with polyuria and 15 without polyuria). The children will be aged 7-14 years of age. The sleep will be evaluated on sleep quality, number of periodic limb movements per hour, blood pressure and pulse, beat to beat variation by electrocardiography during sleep, respiration during sleep, nocturnal urine production, and enuresis episodes.

NCT ID: NCT03389412 Completed - Enuresis, Nocturnal Clinical Trials

The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

DRYCHILD
Start date: October 1, 2017
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate the importance of clinical characterization of children with monosymptomatic nocturnal enuresis (MNE) in order to improve treatment efficacy. The hypothesis is that clinical characterization by measurement of nocturnal urine production and maximal voided volumes in children with MNE and subsequent treatment tailoring improves the response to first-line treatment approach.

NCT ID: NCT03199508 Recruiting - Nocturnal Enuresis Clinical Trials

Clinical Values of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Nocturnal enuresis is common problem in children who are from 5 to 18 years old and do not spontaneously urinate at least 2 times a week for more than 3 months. It can lead to major distress for the children and their parents. The investigators hypothesize that the 3-day voiding diary as the same as the 7-day voiding diary could be a diagnostic tool to provide information on the diagnosis and classification of nocturnal enuresis. The purpose of this study is to investigate the reliability and sensitivity of 3-day versus 7-day voiding diary to diagnose nocturnal enuresis.

NCT ID: NCT03147599 Completed - Bladder Cancer Clinical Trials

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Start date: May 15, 2017
Phase: Phase 4
Study type: Interventional

A randomized controlled trial to assess clinically the efficacy of the selective ileum spasmolytic mebeverine on daytime incontinence and nocturnal enuresis of orthotopic w-ileal neobladders and quality of life effect within 1 year post-surgery.

NCT ID: NCT03047720 Completed - Nocturnal Enuresis Clinical Trials

Scheduled Awakenings for the Treatment of Nocturnal Enuresis

Start date: November 4, 2016
Phase: N/A
Study type: Interventional

This study is a simple effectiveness trial to determine if the Lully Sleep Guardian has any effect on benign nocturnal enuresis.